Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-27 Sale |
2023-12-28 4:28 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
30,000 | $12.02 | $360,453 | 127,532 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:34 pm |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
7,985 | $8.2293 | $65,711 | 92,979 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:33 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
4,958 | $8.2293 | $40,801 | 117,010 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:32 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
7,113 | $8.2293 | $58,535 | 83,228 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:31 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
13,008 | $8.2293 | $107,047 | 192,187 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:30 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
14,807 | $8.2293 | $121,851 | 271,138 (Direct) |
View |
| 2023-09-11 Sale |
2023-09-13 4:29 pm |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
18,000 | $10.5 | $189,050 | 0 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 8:09 pm |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
8,020 | $10.73 | $86,045 | 88,881 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 8:07 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
4,976 | $10.73 | $53,386 | 114,676 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 8:06 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
7,142 | $10.73 | $76,624 | 83,049 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 8:05 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
13,067 | $10.73 | $140,192 | 184,362 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 8:05 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
14,876 | $10.73 | $159,602 | 273,112 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 9:20 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
2,604 | $10.14 | $26,416 | 112,066 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 9:19 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
4,037 | $10.14 | $40,953 | 259,930 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 9:18 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
1,786 | $10.14 | $18,118 | 141,527 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 9:17 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
5,627 | $10.14 | $57,083 | 350,489 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 9:16 pm |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
2,780 | $10.14 | $28,201 | 130,652 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-23 5:44 pm |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
3,412 | $7.66 | $26,136 | 40,791 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-23 5:44 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
2,228 | $7.66 | $17,066 | 87,411 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-23 5:42 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
2,727 | $7.66 | $20,889 | 58,768 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-23 5:41 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
4,954 | $7.66 | $37,948 | 104,243 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-23 5:40 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
6,700 | $7.66 | $51,322 | 196,392 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-21 4:21 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,139 | $5.44 | $6,196 | 59,065 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-21 4:20 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
722 | $5.44 | $3,928 | 102,253 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-21 4:18 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
530 | $5.44 | $2,883 | 87,209 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-21 4:17 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
1,785 | $5.44 | $9,710 | 196,148 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-21 4:15 pm |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
722 | $5.44 | $3,928 | 39,809 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2023-12-28 4:28 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
0 | $0 | 3,573,714 (Indirect) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:34 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
37,060 | $0 | 92,979 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
22,994 | $0 | 117,010 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:32 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
22,994 | $0 | 83,228 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:31 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
60,394 | $0 | 192,187 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:30 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
67,166 | $0 | 271,138 (Direct) |
View |
| 2023-10-30 Gift |
2023-11-01 4:12 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
8,000 | $0 | 138,756 (Direct) |
View |
| 2023-09-26 Option Award |
2023-09-28 4:55 pm |
N/A 2033-09-25 |
KalVista Pharmaceuticals Inc. | KALV | Treanor Patrick Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-26 Option Award |
2023-09-28 4:54 pm |
N/A 2033-09-25 |
KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-26 Option Award |
2023-09-28 4:54 pm |
N/A 2033-09-25 |
KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-26 Option Award |
2023-09-28 4:53 pm |
N/A 2033-09-25 |
KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-26 Option Award |
2023-09-28 4:52 pm |
N/A 2033-09-25 |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-11 Exercise |
2023-09-13 4:29 pm |
N/A 2027-09-27 |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
18,000 | $0 | 0 (Direct) |
View |
| 2023-09-11 Exercise |
2023-09-13 4:29 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
6,000 | $6.71 | 0 (Direct) |
View |
| 2023-09-11 Exercise |
2023-09-13 4:29 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
12,000 | $7.88 | 0 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-21 8:09 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
37,058 | $0 | 88,881 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-21 8:07 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
22,988 | $0 | 114,676 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-21 8:06 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
22,988 | $0 | 83,049 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-21 8:05 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
60,390 | $0 | 184,362 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-21 8:05 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
67,164 | $0 | 273,112 (Direct) |
View |
| 2023-02-17 Exercise(A) |
2023-05-22 9:40 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
2,430 | $0 | 26,736 (Direct) |
View |
| 2023-02-17 Exercise(A) |
2023-05-22 9:39 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
6,944 | $0 | 76,390 (Direct) |
View |
| 2023-02-17 Exercise(A) |
2023-05-22 9:37 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
2,430 | $0 | 26,736 (Direct) |
View |
| 2023-02-17 Exercise(A) |
2023-05-22 9:36 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
6,944 | $0 | 76,390 (Direct) |
View |
| 2023-02-17 Exercise(A) |
2023-05-22 9:35 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
4,027 | $0 | 44,307 (Direct) |
View |
| 2023-05-18 Option Award |
2023-05-22 9:33 pm |
N/A 2033-05-17 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 9:20 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
8,410 | $0 | 112,066 (Direct) |
View |
| 2023-01-11 Option Award |
2023-05-19 9:20 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
29,166 | $0 | 112,066 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 9:19 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
18,728 | $0 | 259,930 (Direct) |
View |
| 2023-01-11 Option Award |
2023-05-19 9:19 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
83,334 | $0 | 259,930 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 9:18 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
8,410 | $0 | 141,527 (Direct) |
View |
| 2023-01-11 Option Award |
2023-05-19 9:18 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
29,166 | $0 | 141,527 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 9:17 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
25,500 | $0 | 350,489 (Direct) |
View |
| 2023-01-11 Option Award |
2023-05-19 9:17 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
83,334 | $0 | 350,489 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 9:16 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
12,894 | $0 | 130,652 (Direct) |
View |
| 2023-01-11 Option Award |
2023-05-19 9:16 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
48,334 | $0 | 130,652 (Direct) |
View |
| 2023-02-17 Exercise |
2023-02-23 5:44 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
12,892 | $0 | 40,791 (Direct) |
View |
| 2023-02-17 Exercise |
2023-02-23 5:44 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
8,408 | $0 | 87,411 (Direct) |
View |
| 2023-02-17 Exercise |
2023-02-23 5:42 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
8,408 | $0 | 58,768 (Direct) |
View |
| 2023-02-17 Exercise |
2023-02-23 5:41 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
18,726 | $0 | 104,243 (Direct) |
View |
| 2023-02-17 Exercise |
2023-02-23 5:40 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
25,498 | $0 | 196,392 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:21 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,774 | $0 | 59,065 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:20 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO & Secretary |
2,419 | $0 | 102,253 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:18 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
1,774 | $0 | 87,209 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:17 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
5,805 | $0 | 196,148 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:15 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
2,419 | $0 | 39,809 (Direct) |
View |